Differential uptake of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea and doxorubicin by Lewis lung carcinoma and Ridgway osteogenic sarcoma.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000097:blood / Q000378:metabolism*; D005260:Female; D007274:Injections, Intraperitoneal; D008175:Lung Neoplasms / Q000378:metabolism*; D051379:Mice; D009607:Nitrosourea Compounds / Q000378:metabolism*; D012516:Osteosarcoma / Q000378:metabolism*; D012673:Semustine / Q000097:blood / Q000378:metabolism*; D013045:Species Specificity
D009607:Nitrosourea Compounds; D012673:Semustine; D004317:Doxorubicin